A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas - PubMed (original) (raw)
Comparative Study
A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas
R A Soslow et al. Breast Cancer Res Treat. 2000 May.
Abstract
Infiltrating lobular carcinoma (ILC) and infiltrating ductal carcinoma (IDC) are similar in many respects and their histologic features occasionally overlap. Despite the many similarities, some clinical follow-up data and the patterns of metastasis suggest that ILC and IDC are biologically distinct. Unfortunately, most breast cancer research has focused almost exclusively on the ductal subtype or has not stressed the biologic or molecular genetic distinctions between breast carcinoma subtypes. Several reports have suggested the possibility that ILCs and IDCs differ with respect to expression of antigens involved in proliferation and cell cycle regulation. Therefore, we undertook an immunohistochemical evaluation of cell cycle related antigens in ILCs, including histologic variants thought to represent aggressive neoplasms, and IDCs matched for histologic grade (Modified Bloom-Richardson Grade I). We believe that different antigen expression profiles could elucidate the biological distinctiveness of breast carcinoma subtypes and possibly provide diagnostically relevant information. We studied the expression of the following antigens in 28 archived, formalin-fixed ILCs and 34 well-differentiated IDCs: estrogen receptor (ER), progesterone receptor (PR), Her 2-neu, mib-1, cyclin D1, p27, p53, mdm-2 and bcl-2. 94% of ILCs and 100% of IDCs expressed ER; 75% of ILCs and 76% of IDCs expressed PR; 4% of ILCs and 13% of IDCs expressed c cerb B-2; ILCs and IDCs both expressed mib-1 in approximately 10% of lesional cells; 82% of ILCs and 54% of IDCs expressed cyclin D1; 90% of ILCs and 83% IDCs expressed p27 strongly; 4% of ILCs and 4% of IDCs expressed p53, 25% of ILCs and 33% of IDCs expressed mdm-2; 96% of ILCs and 100% of IDCs expressed bcl-2. None of the apparent differences were statistically significant. The ILC variants demonstrated immunophenotypes that were essentially similar to ILCs of the usual type. We conclude that ILCs and well-differentiated IDCs show similar proliferation and cell cycle control antigen profiles. Despite their unusual histologic features, most ILC variants appear to maintain a characteristic ILC immunophenotype.
Similar articles
- Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.
Arpino G, Bardou VJ, Clark GM, Elledge RM. Arpino G, et al. Breast Cancer Res. 2004;6(3):R149-56. doi: 10.1186/bcr767. Epub 2004 Feb 17. Breast Cancer Res. 2004. PMID: 15084238 Free PMC article. - Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast.
Oyama T, Kashiwabara K, Yoshimoto K, Arnold A, Koerner F. Oyama T, et al. Cancer Res. 1998 Jul 1;58(13):2876-80. Cancer Res. 1998. PMID: 9661905 - Cyclin D1 in breast cancer.
Barnes DM, Gillett CE. Barnes DM, et al. Breast Cancer Res Treat. 1998;52(1-3):1-15. doi: 10.1023/a:1006103831990. Breast Cancer Res Treat. 1998. PMID: 10066068 Review. - Differentiation of tumours of ductal and lobular origin: I. Proteomics of invasive ductal and lobular breast carcinomas.
Turashvili G, Bouchal J, Burkadze G, Kolár Z. Turashvili G, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):57-62. doi: 10.5507/bp.2005.005. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005. PMID: 16170389 Review.
Cited by
- p27 deregulation in breast cancer: prognostic significance and implications for therapy.
Alkarain A, Jordan R, Slingerland J. Alkarain A, et al. J Mammary Gland Biol Neoplasia. 2004 Jan;9(1):67-80. doi: 10.1023/B:JOMG.0000023589.00994.5e. J Mammary Gland Biol Neoplasia. 2004. PMID: 15082919 Review. - Deregulation of p27 by oncogenic signaling and its prognostic significance in breast cancer.
Alkarain A, Slingerland J. Alkarain A, et al. Breast Cancer Res. 2004;6(1):13-21. doi: 10.1186/bcr722. Epub 2003 Oct 21. Breast Cancer Res. 2004. PMID: 14680481 Free PMC article. Review. - Different gene expression patterns in invasive lobular and ductal carcinomas of the breast.
Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale AL, Jeffrey SS. Zhao H, et al. Mol Biol Cell. 2004 Jun;15(6):2523-36. doi: 10.1091/mbc.e03-11-0786. Epub 2004 Mar 19. Mol Biol Cell. 2004. PMID: 15034139 Free PMC article. - The cyclin dependent kinase inhibitor p27 and its prognostic role in breast cancer.
Chiarle R, Pagano M, Inghirami G. Chiarle R, et al. Breast Cancer Res. 2001;3(2):91-4. doi: 10.1186/bcr277. Epub 2000 Dec 20. Breast Cancer Res. 2001. PMID: 11250752 Free PMC article. Review. - Clinical Characteristics and Survival Outcomes of Infiltrating Lobular Carcinoma: A Retrospective Study of 365 Cases in China.
Han B, Gu Z, Liu Z, Ling H. Han B, et al. Cancer Manag Res. 2022 Feb 16;14:647-658. doi: 10.2147/CMAR.S346319. eCollection 2022. Cancer Manag Res. 2022. PMID: 35210861 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous